Du Laing, 73 patient zinc sufficiency study: 79% lower mortality [p=0.01] https://c19p.org/dulaing
copied to clipboard
Course and Survival of COVID-19 Patients with Comorbidities in Relation to the Trace Element Status at Hospital Admission
et al., Nutrients, doi:10.3390/nu13103304
Retrospective 73 hospitalized COVID-19 patients in Belgium, showing higher risk of mortality with selenium deficiency and zinc deficiency.
|
risk of death, 79.0% lower, RR 0.21, p = 0.01, high zinc levels (≥660µg/L) 3 of 49 (6.1%), low zinc levels (<660µg/L) 7 of 24 (29.2%), NNT 4.3.
|
|
risk of death, 78.4% lower, RR 0.22, p = 0.03, high zinc levels (≥660µg/L) 2 of 17 (11.8%), low zinc levels (<660µg/L) 6 of 11 (54.5%), NNT 2.3, >65 years.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
This study is excluded in the after exclusion results of meta
analysis:
unadjusted results with no group details.
Du Laing et al., 9/22/2021, retrospective, Belgium, Europe, peer-reviewed, 11 authors.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.